Related Experiment Video
Updated: Jul 4, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Angiotensin I-converting enzyme I/D polymorphism and suicidal behaviors
D Larry Sparks1, John C Hunsaker, Philippe Amouyel
1Sun Health Research Institute, Sun City, Arizona, USA.
Summary
Genetic factors influence suicidal behavior. A study found the angiotensin-converting enzyme (ACE) gene
Area of Science:
- Genetics
- Psychiatry
- Molecular Biology
Background:
- Suicide is a significant cause of death globally, often linked to genetic predispositions and major depression.
- The angiotensin-converting enzyme (ACE) gene and its insertion/deletion (I/D) polymorphism have been implicated in various physiological processes.
Purpose of the Study:
- To investigate the association between the ACE I/D polymorphism and suicidal behavior.
- To determine if specific genotypes of the ACE gene increase the risk for suicide completion or attempts.
Main Methods:
- Two independent case-control studies were conducted.
- Study 1 included 64 suicide completers and 90 controls undergoing forensic investigation.
- Study 2 involved 588 suicide attempters and 639 controls.
Main Results:
- A statistically significant association was found between the DD genotype of the ACE I/D polymorphism and an increased risk of suicidal behavior.
- This finding was consistent across both studied populations.
Conclusions:
- The results suggest a potential role for the renin-angiotensin system, influenced by the ACE gene, in the biological mechanisms underlying suicidal behavior.
- Further research is warranted to explore the implications of the ACE I/D polymorphism in suicide prevention strategies.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...